890090-42-3 ((5,6-Diamino-3',6'-bis(diethylamino)-3H-spiroisobenzofuran-1,9'-xanthen-3-one)

快速询单

结构式：

5,6-Diamino-3',6'-bis(diethylamino)-3H-spiroisobenzofuran-1,9'-xanthen-3-oneMOL文件

CAS号：

890090-42-3

英文名称：

5,6-Diamino-3',6'-bis(diethylamino)-3H-spiroisobenzofuran-1,9'-xanthen-3-one

分子式：

C₂₈H₃₂N₄O₃

分子量：

472.578686714172

5,6-Diamino-3',6'-bis(diethylamino)-3H-spiroisobenzofuran-1,9'-xanthen-3-one(890090-42-3)名称与标识符

名称

英文别名：

5,6-diamino-3',6'-bis(diethylamino)spiro[2-benzofuran-3,9'-xanthene]-1-one;5,6-Diamino-3',6'-bis(diethylamino)-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one;

标识符

MDL：

MFCD08276989

InChIKey：

LJSMMWFTVBPRDS-UHFFFAOYSA-N

Inchi：

1S/C28H32N4O3/c1-5-31(6-2)17-9-11-20-25(13-17)34-26-14-18(32(7-3)8-4)10-12-21(26)28(20)22-16-24(30)23(29)15-19(22)27(33)35-28/h9-16H,5-8,29-30H2,1-4H3

SMILES：

O1C2(C3=C(C=C(N(CC)CC)C=C3)OC3=C2C=CC(N(CC)CC)=C3)C2=CC(N)=C(N)C=C2C1=O

5,6-Diamino-3',6'-bis(diethylamino)-3H-spiroisobenzofuran-1,9'-xanthen-3-one(890090-42-3)物化性质

计算特性

氢键供体数量 : 2
氢键受体数量 : 7
可旋转化学键数量 : 6
重原子数量 : 35

5,6-Diamino-3',6'-bis(diethylamino)-3H-spiroisobenzofuran-1,9'-xanthen-3-one(890090-42-3)相关文献

1. Site-selective modification strategies in antibody–drug conjugates
Stephen J. Walsh,Jonathan D. Bargh,Friederike M. Dannheim,Abigail R. Hanby,Hikaru Seki,Andrew J. Counsell,Xiaoxu Ou,Elaine Fowler,Nicola Ashman,Yuri Takada,Albert Isidro-Llobet,Jeremy S. Parker,Jason S. Carroll,David R. Spring Chem. Soc. Rev. 2021 50 1305
2. A homogeneous high-DAR antibody–drug conjugate platform combining THIOMAB antibodies and XTEN polypeptides
Neelie Zacharias,Vladimir N. Podust,Kimberly K. Kajihara,Douglas Leipold,Geoffrey Del Rosario,Desiree Thayer,Emily Dong,Maciej Paluch,David Fischer,Kai Zheng,Corinna Lei,Jintang He,Carl Ng,Dian Su,Luna Liu,Shabkhaiz Masih,William Sawyer,Jeff Tinianow,Jan Marik,Victor Yip,Guangmin Li,Josefa Chuh,J. Hiroshi Morisaki,Summer Park,Bing Zheng,Hilda Hernandez-Barry,Kelly M. Loyet,Min Xu,Katherine R. Kozak,Gail Lewis Phillips,Ben-Quan Shen,Cong Wu,Keyang Xu,Shang-Fan Yu,Amrita Kamath,Rebecca K. Rowntree,Dorothea Reilly,Thomas Pillow,Andrew Polson,Volker Schellenberger,Wouter L. W. Hazenbos,Jack Sadowsky Chem. Sci. 2022 13 3147
3. Next generation maleimides enable the controlled assembly of antibody–drug conjugates via native disulfide bond bridging
Felix F. Schumacher,Jo?o P. M. Nunes,Antoine Maruani,Vijay Chudasama,Mark E. B. Smith,Kerry A. Chester,James R. Baker,Stephen Caddick Org. Biomol. Chem. 2014 12 7261
4. Enabling the controlled assembly of antibody conjugates with a loading of two modules without antibody engineering
Maximillian T. W. Lee,Antoine Maruani,Daniel A. Richards,James R. Baker,Stephen Caddick,Vijay Chudasama Chem. Sci. 2017 8 2056
5. Development of a facile antibody–drug conjugate platform for increased stability and homogeneity
Nimish Gupta,Johny Kancharla,Shelly Kaushik,Aasif Ansari,Samad Hossain,Ravinder Goyal,Manoj Pandey,Jwala Sivaccumar,Sazid Hussain,Arindam Sarkar,Aniruddha Sengupta,Swadhin K. Mandal,Monideepa Roy,Shiladitya Sengupta Chem. Sci. 2017 8 2387
6. Self-exploding capsules
Bruno G. De Geest,Stefaan De Koker,Jo Demeester,Stefaan C. De Smedt,Wim E. Hennink Polym. Chem. 2010 1 137
7. Towards the next generation of biomedicines by site-selective conjugation
Qi-Ying Hu,Francesco Berti,Roberto Adamo Chem. Soc. Rev. 2016 45 1691
8. Pyridazinediones deliver potent, stable, targeted and efficacious antibody–drug conjugates (ADCs) with a controlled loading of 4 drugs per antibody
Eifion Robinson,Jo?o P. M. Nunes,Vessela Vassileva,Antoine Maruani,Jo?o C. F. Nogueira,Mark E. B. Smith,R. Barbara Pedley,Stephen Caddick,James R. Baker,Vijay Chudasama RSC Adv. 2017 7 9073
9. Understanding the NMR chemical shifts for 6-halopurines: role of structure, solvent and relativistic effects
Stanislav Standara,Kate?ina Maliňáková,Radek Marek,Jaromír Marek,Michal Hocek,Juha Vaara,Michal Straka Phys. Chem. Chem. Phys. 2010 12 5126
10. Site-selective lysine conjugation methods and applications towards antibody–drug conjugates
Muhammed Haque,Nafsika Forte,James R. Baker Chem. Commun. 2021 57 10689

810668-53-2(Methyl (4Z,7S,8E,10Z,12E,14E,16R,17S,19Z)-7,16,17-trihydroxy-4,8, 10,12,14,19-docosahexaenoate) 81115-49-3(6-羧酸-5-氨基-1H-吲唑) 80880-90-6(替仑西平) 812640-83-8((1-(PYRIDIN-2-YL)CYCLOPROPYL)METHANAMINE) 81324-61-0(3-溴-4-甲氧基苯甲酰氯) 80650-47-1(2-chloro-N-(4,5-dihydro-1,3-thiazol-2-yl)acetamide) 809231-57-0(L-2-(BOC-AMINO)-3-(4'-METHOXYBIPHENYL-4-YL)PROPANOIC ACID) 811431-33-1(1-(6-氨基-9H-嘌呤-9-基)-1,5-二脱氧-2,3-O-(1-甲基亚乙基)-BETA-D-呋喃核己糖醛酸)

960化工网为您提供5,6-Diamino-3',6'-bis(diethylamino)-3H-spiroisobenzofuran-1,9'-xanthen-3-one专业化合物百科信息，包括中文名，英文名，分子式，分子量，以及该化合物的CasNo.890090-42-3,相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等。 WAP版:890090-42-3 国际站:890090-42-3

890090-42-3 ((5,6-Diamino-3',6'-bis(diethylamino)-3H-spiroisobenzofuran-1,9'-xanthen-3-one)

5,6-Diamino-3',6'-bis(diethylamino)-3H-spiroisobenzofuran-1,9'-xanthen-3-one(890090-42-3)名称与标识符

名称

标识符

5,6-Diamino-3',6'-bis(diethylamino)-3H-spiroisobenzofuran-1,9'-xanthen-3-one(890090-42-3)物化性质

计算特性

5,6-Diamino-3',6'-bis(diethylamino)-3H-spiroisobenzofuran-1,9'-xanthen-3-one(890090-42-3)相关文献

目录